- Featured News /
Cell Therapies Pty Ltd has become the first approved CAR-T commercial manufacturing site in Australia, providing potentially faster access to CAR-T therapies to eligible patients in the region with life-threatening blood cancers.
Novartis global commercial CAR-T manufacturing footprint now spans four continents, bringing these transformative therapies closer to patients and healthcare professionals around the world. - Featured News /
Learn how we’re working with partners like the International Agency for the Prevention of Blindness to eliminate preventable blindness.
- Featured News /
Novartis included in Dow Jones Sustainability World Index, with industry-leading performance in environmental and social reporting and human capital.
- Featured News /
September 29 is World Heart Day. For the past six decades, Novartis has been working to advance heart health around the world.
- Featured News /
The RUXCOVID clinical trial highlights the Novartis commitment to leverage our expertise and resources to support the global response to the COVID-19 pandemic.
- Featured News /
NIBR translational immunologists and academic colleagues observe two distinct molecular patterns of disease progression in lung tissue samples.
- Featured News /
To celebrate International Women’s Day we explore how an inclusive environment that values unique and curious minds helps everyone be inspired to innovate every day.
- Featured News /
At Novartis, we aim to be a leader in environmental sustainability and a catalyst for positive change both in our own operations and in our supply chain.
- Featured News /
AI offers the greatest potential to transform health systems from being reactive to proactive, predictive, and even preventive.
- Featured News /
COVID-19 is disrupting Africa’s health services – potentially undermining decades of progress on child health.
Pagination
- ‹ Previous page
- 1
- …
- 100
- 101
- 102
- 103
- 104
- 105
- 106
- …
- 277
- › Next page